Global Neuroendocrine Tumor Treatment Market Analysis 2015-2019 and Forecast 2020-2025
- 99S3755092
- 85 Pages
- February 2020
- Healthcare
The global Neuroendocrine Tumor Treatment market size is estimated at xxx million USD with a CAGR xx% from 2015-2019 and is expected to reach xxx Million USD in 2020 with a CAGR xx% from 2020 to 2025. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Neuroendocrine Tumor Treatment by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Everolimus
Sunitinib
Lu-Dotatate
Lanreotide
Octreotide
Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):
Exelixis, Inc.
Advanced Accelerator Applications
Dauntless Pharmaceuticals, Inc.
Hutchinson Medipharma Limited
Ispen
Novartis AG
Progenics Pharmaceuticals, Inc.
Tarveda Therapeutics
Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Hospitals
Clinic
Others
Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
1 Industry Overview
1.1 Neuroendocrine Tumor Treatment Industry
Figure Neuroendocrine Tumor Treatment Industry Chain Structure
1.1.1 Overview
1.1.2 Development of Neuroendocrine Tumor Treatment
1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of Neuroendocrine Tumor Treatment
1.2.2 Downstream
Table Application Segment of Neuroendocrine Tumor Treatment
Table Global Neuroendocrine Tumor Treatment Market 2015-2025, by Application, in USD Million
1.3 Cost Analysis
2 Industry Environment (PEST Analysis)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 Neuroendocrine Tumor Treatment Market by Type
3.1 By Type
3.1.1 Everolimus
Table Major Company List of Everolimus
3.1.2 Sunitinib
Table Major Company List of Sunitinib
3.1.3 Lu-Dotatate
Table Major Company List of Lu-Dotatate
3.1.4 Lanreotide
Table Major Company List of Lanreotide
3.1.5 Octreotide
Table Major Company List of Octreotide
3.2 Market Size
Table Global Neuroendocrine Tumor Treatment Market 2015-2019, by Type, in USD Million
Figure Global Neuroendocrine Tumor Treatment Market Growth 2015-2019, by Type, in USD Million
Table Global Neuroendocrine Tumor Treatment Market 2015-2019, by Type, in Volume
Figure Global Neuroendocrine Tumor Treatment Market Growth 2015-2019, by Type, in Volume
3.3 Market Forecast
Table Global Neuroendocrine Tumor Treatment Market Forecast 2020-2025, by Type, in USD Million
Table Global Neuroendocrine Tumor Treatment Market Forecast 2020-2025, by Type, in Volume
4 Major Companies List
4.1 Exelixis, Inc. (Company Profile, Sales Data etc.)
4.1.1 Exelixis, Inc. Profile
Table Exelixis, Inc. Overview List
4.1.2 Exelixis, Inc. Products & Services
4.1.3 Exelixis, Inc. Business Operation Conditions
Table Business Operation of Exelixis, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 Advanced Accelerator Applications (Company Profile, Sales Data etc.)
4.2.1 Advanced Accelerator Applications Profile
Table Advanced Accelerator Applications Overview List
4.2.2 Advanced Accelerator Applications Products & Services
4.2.3 Advanced Accelerator Applications Business Operation Conditions
Table Business Operation of Advanced Accelerator Applications (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.3 Dauntless Pharmaceuticals, Inc. (Company Profile, Sales Data etc.)
4.3.1 Dauntless Pharmaceuticals, Inc. Profile
Table Dauntless Pharmaceuticals, Inc. Overview List
4.3.2 Dauntless Pharmaceuticals, Inc. Products & Services
4.3.3 Dauntless Pharmaceuticals, Inc. Business Operation Conditions
Table Business Operation of Dauntless Pharmaceuticals, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.4 Hutchinson Medipharma Limited (Company Profile, Sales Data etc.)
4.4.1 Hutchinson Medipharma Limited Profile
Table Hutchinson Medipharma Limited Overview List
4.4.2 Hutchinson Medipharma Limited Products & Services
4.4.3 Hutchinson Medipharma Limited Business Operation Conditions
Table Business Operation of Hutchinson Medipharma Limited (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.5 Ispen (Company Profile, Sales Data etc.)
4.5.1 Ispen Profile
Table Ispen Overview List
4.5.2 Ispen Products & Services
4.5.3 Ispen Business Operation Conditions
Table Business Operation of Ispen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.6 Novartis AG (Company Profile, Sales Data etc.)
4.6.1 Novartis AG Profile
Table Novartis AG Overview List
4.6.2 Novartis AG Products & Services
4.6.3 Novartis AG Business Operation Conditions
Table Business Operation of Novartis AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.7 Progenics Pharmaceuticals, Inc. (Company Profile, Sales Data etc.)
4.7.1 Progenics Pharmaceuticals, Inc. Profile
Table Progenics Pharmaceuticals, Inc. Overview List
4.7.2 Progenics Pharmaceuticals, Inc. Products & Services
4.7.3 Progenics Pharmaceuticals, Inc. Business Operation Conditions
Table Business Operation of Progenics Pharmaceuticals, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.8 Tarveda Therapeutics (Company Profile, Sales Data etc.)
4.8.1 Tarveda Therapeutics Profile
Table Tarveda Therapeutics Overview List
4.8.2 Tarveda Therapeutics Products & Services
4.8.3 Tarveda Therapeutics Business Operation Conditions
Table Business Operation of Tarveda Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
5 Market Competition
5.1 Company Competition
Table Global Neuroendocrine Tumor Treatment Sales Revenue 2015-2019, by Company, in USD Million
Table Global Neuroendocrine Tumor Treatment Sales Revenue Share 2015-2019, by Company, in USD Million
Figure Global Neuroendocrine Tumor Treatment Sales Revenue Share in 2019, by Company, in USD Million
Table Global Neuroendocrine Tumor Treatment Sales Volume 2015-2019, by Company, in Volume
Table Global Neuroendocrine Tumor Treatment Sales Volume Share 2015-2019, by Company, in Volume
Figure Global Neuroendocrine Tumor Treatment Sales Volume Share in 2019, by Company, in Volume
5.2 Regional Market by Company
Figure North America Neuroendocrine Tumor Treatment Market Concentration, in 2019
Figure Europe Neuroendocrine Tumor Treatment Market Market Concentration, in 2019
Figure Asia-Pacific Neuroendocrine Tumor Treatment MMarket Concentration, in 2019
Figure South America Neuroendocrine Tumor Treatment Market Concentration, in 2019
Figure Middle East & Africa Neuroendocrine Tumor Treatment Market Concentration, in 2019
6 Demand by End Market
6.1 Demand Situation
6.1.1 Demand in Hospitals
Figure Neuroendocrine Tumor Treatment Demand in Hospitals, 2015-2019, in USD Million
Figure Neuroendocrine Tumor Treatment Demand in Hospitals, 2015-2019, in Volume
6.1.2 Demand in Clinic
Figure Neuroendocrine Tumor Treatment Demand in Clinic, 2015-2019, in USD Million
Figure Neuroendocrine Tumor Treatment Demand in Clinic, 2015-2019, in Volume
6.1.3 Demand in Others
Figure Neuroendocrine Tumor Treatment Demand in Others, 2015-2019, in USD Million
Figure Neuroendocrine Tumor Treatment Demand in Others, 2015-2019, in Volume
6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions
6.3 Demand Forecast
Table Neuroendocrine Tumor Treatment Demand Forecast 2020-2025, by Application, in USD Million
Figure Neuroendocrine Tumor Treatment Market Growth 2020-2025, by Application, in USD Million
Figure Neuroendocrine Tumor Treatment Market Share in 2025, by Application, in USD Million
Table Neuroendocrine Tumor Treatment Demand Forecast 2020-2025, by Application, in Volume
Table Neuroendocrine Tumor Treatment Market Growth 2020-2025, by Application, in Volume
Table Neuroendocrine Tumor Treatment Market Share in 2025, by Application, in Volume
7 Region Operation
7.1 Regional Production
Table Neuroendocrine Tumor Treatment Production 2015-2019, by Region, in USD Million
Table Neuroendocrine Tumor Treatment Production 2015-2019, by Region, in Volume
7.2 Regional Market
Table Global Neuroendocrine Tumor Treatment Market 2015-2019, by Region, in USD Million
Table Global Neuroendocrine Tumor Treatment Market Share 2015-2019, by Region, in USD Million
Table Global Neuroendocrine Tumor Treatment Market 2015-2019, by Region, in Volume
Table Global Neuroendocrine Tumor Treatment Market Share 2015-2019, by Region, in Volume
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
Figure North America Neuroendocrine Tumor Treatment Market Size and Growth 2015-2019, in USD Million
Figure North America Neuroendocrine Tumor Treatment Market Size and Growth 2015-2019, in Volume
7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America Neuroendocrine Tumor Treatment Market Size 2015-2019, by Country, in USD Million
Table North America Neuroendocrine Tumor Treatment Market Size 2015-2019, by Country, in Volume
7.3.2 Europe
7.3.2.1 Overview
Figure Europe Neuroendocrine Tumor Treatment Market Size and Growth 2015-2019, in USD Million
Figure Europe Neuroendocrine Tumor Treatment Market Size and Growth 2015-2019, in Volume
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe Neuroendocrine Tumor Treatment Market Size 2015-2019, by Country, in USD Million
Table Europe Neuroendocrine Tumor Treatment Market Size 2015-2019, by Country, in Volume
7.3.3 Asia-Pacific
7.3.3.1 Overview
Figure Asia-Pacific Neuroendocrine Tumor Treatment Market Size and Growth 2015-2019, in USD Million
Figure Asia-Pacific Neuroendocrine Tumor Treatment Market Size and Growth 2015-2019, in Volume
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific Neuroendocrine Tumor Treatment Market Size 2015-2019, by Country, in USD Million
Table Asia-Pacific Neuroendocrine Tumor Treatment Market Size 2015-2019, by Country, in Volume
7.3.4 South America
7.3.4.1 Overview
Figure South America Neuroendocrine Tumor Treatment Market Size and Growth 2015-2019, in USD Million
Figure South America Neuroendocrine Tumor Treatment Market Size and Growth 2015-2019, in Volume
7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America Neuroendocrine Tumor Treatment Market Size 2015-2019, by Country, in USD Million
Table South America Neuroendocrine Tumor Treatment Market Size 2015-2019, by Country, in Volume
7.3.5 Middle East & Africa
7.3.5.1 Overview
Figure Middle East & Africa Neuroendocrine Tumor Treatment Market Size and Growth 2015-2019, in USD Million
Figure Middle East & Africa Neuroendocrine Tumor Treatment Market Size and Growth 2015-2019, in Volume
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa Neuroendocrine Tumor Treatment Market Size 2015-2019, by Country, in USD Million
Table Middle East & Africa Neuroendocrine Tumor Treatment Market Size 2015-2019, by Country, in Volume
7.4 Regional Import & Export
7.5 Regional Forecast
Table Neuroendocrine Tumor Treatment Market Forecast 2020-2025, by Region, in USD Million
Table Neuroendocrine Tumor Treatment Market Forecast 2020-2025, by Region, in Volume
8 Marketing & Price
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
Table Price Factors List
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
Figure Marketing Channels Overview
9 Research Conclusion
Table Upstream Segment of Neuroendocrine Tumor Treatment
Table Application Segment of Neuroendocrine Tumor Treatment
Table Global Neuroendocrine Tumor Treatment Market 2015-2025, by Application, in USD Million
Table Major Company List of Sunitinib
Table Major Company List of Lu-Dotatate
Table Major Company List of Lanreotide
Table Major Company List of Octreotide
Table Global Neuroendocrine Tumor Treatment Market 2015-2019, by Type, in USD Million
Table Global Neuroendocrine Tumor Treatment Market 2015-2019, by Type, in Volume
Table Global Neuroendocrine Tumor Treatment Market Forecast 2020-2025, by Type, in USD Million
Table Global Neuroendocrine Tumor Treatment Market Forecast 2020-2025, by Type, in Volume
Table Exelixis, Inc. Overview List
Table Business Operation of Exelixis, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Advanced Accelerator Applications Overview List
Table Business Operation of Advanced Accelerator Applications (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Dauntless Pharmaceuticals, Inc. Overview List
Table Business Operation of Dauntless Pharmaceuticals, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Hutchinson Medipharma Limited Overview List
Table Business Operation of Hutchinson Medipharma Limited (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Ispen Overview List
Table Business Operation of Ispen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Novartis AG Overview List
Table Business Operation of Novartis AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Progenics Pharmaceuticals, Inc. Overview List
Table Business Operation of Progenics Pharmaceuticals, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Tarveda Therapeutics Overview List
Table Business Operation of Tarveda Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Global Neuroendocrine Tumor Treatment Sales Revenue 2015-2019, by Company, in USD Million
Table Global Neuroendocrine Tumor Treatment Sales Revenue Share 2015-2019, by Company, in USD Million
Table Global Neuroendocrine Tumor Treatment Sales Volume 2015-2019, by Company, in Volume
Table Global Neuroendocrine Tumor Treatment Sales Volume Share 2015-2019, by Company, in Volume
Table Regional Demand Comparison List
Table Major Application in Different Regions
Table Neuroendocrine Tumor Treatment Demand Forecast 2020-2025, by Application, in USD Million
Table Neuroendocrine Tumor Treatment Demand Forecast 2020-2025, by Application, in Volume
Table Neuroendocrine Tumor Treatment Market Growth 2020-2025, by Application, in Volume
Table Neuroendocrine Tumor Treatment Market Share in 2025, by Application, in Volume
Table Neuroendocrine Tumor Treatment Production 2015-2019, by Region, in USD Million
Table Neuroendocrine Tumor Treatment Production 2015-2019, by Region, in Volume
Table Global Neuroendocrine Tumor Treatment Market 2015-2019, by Region, in USD Million
Table Global Neuroendocrine Tumor Treatment Market Share 2015-2019, by Region, in USD Million
Table Global Neuroendocrine Tumor Treatment Market 2015-2019, by Region, in Volume
Table Global Neuroendocrine Tumor Treatment Market Share 2015-2019, by Region, in Volume
Table North America Neuroendocrine Tumor Treatment Market Size 2015-2019, by Country, in USD Million
Table North America Neuroendocrine Tumor Treatment Market Size 2015-2019, by Country, in Volume
Table Europe Neuroendocrine Tumor Treatment Market Size 2015-2019, by Country, in USD Million
Table Europe Neuroendocrine Tumor Treatment Market Size 2015-2019, by Country, in Volume
Table Asia-Pacific Neuroendocrine Tumor Treatment Market Size 2015-2019, by Country, in USD Million
Table Asia-Pacific Neuroendocrine Tumor Treatment Market Size 2015-2019, by Country, in Volume
Table South America Neuroendocrine Tumor Treatment Market Size 2015-2019, by Country, in USD Million
Table South America Neuroendocrine Tumor Treatment Market Size 2015-2019, by Country, in Volume
Table Middle East & Africa Neuroendocrine Tumor Treatment Market Size 2015-2019, by Country, in USD Million
Table Middle East & Africa Neuroendocrine Tumor Treatment Market Size 2015-2019, by Country, in Volume
Table Neuroendocrine Tumor Treatment Market Forecast 2020-2025, by Region, in USD Million
Table Neuroendocrine Tumor Treatment Market Forecast 2020-2025, by Region, in Volume
Table Price Factors List
Similar Reports
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
- Publish Date: March 2, 2020
- $0
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
- Publish Date: March 10, 2011
- $950
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...
- Publish Date: July 18, 2011
- $950
